A new way forward in cancer care
CureSeek is an AI-powered second opinion platform that synthesizes your scans, pathology, genomics, and history with the latest oncology research, surfacing personalized, evidence-backed treatment options for you and your care team.
At 16, she was placed on hospice with advanced brain cancer, given one month to live after exhausting every standard treatment. Instead of accepting that outcome, our team analyzed her full molecular data, mapped the biology driving her disease, and identified a targeted, repurposed therapy.
Six years later, she is alive and thriving. Over the past 25 years, this same pathway-based approach has been applied to hundreds of advanced cancer patients, often when conventional medicine had no remaining options.
Even when actionable biomarkers are present in a patient's data, too many people still don't receive the best-matched therapies. CureSeek exists to close that gap.
Tumors with the same name can be molecularly distinct, and respond to entirely different treatments. Yet decisions are often still made based on tissue of origin alone.
Genomic panels, pathology, imaging, and clinical history live in separate systems and formats. Synthesizing them into a coherent strategy is slow, manual work.
Expert analysis can take weeks. For patients with advanced or aggressive disease, that delay can mean missing the therapies that matter most.
Scans, pathology, genomics, surgical notes, EHR exports. Encrypted in transit and at rest, structured by our medical team within hours, not weeks.
We bring your records, scans, and lab results together in one place, then apply the kind of careful, multidisciplinary review usually reserved for top cancer centers, with the speed and consistency of modern technology.
Genetic testing, pathology, scans, and your medical history come together so nothing important gets lost between providers.
Our analysis is trained on decades of real patient outcomes, so the recommendations reflect the specific drivers of your cancer.
Every treatment option, repurposed medication, and trial match is linked to the peer-reviewed evidence behind it.
Your information is encrypted and protected with HIPAA-aligned safeguards. You decide what gets shared, and with whom.
Each report goes deeper into your tumor biology than a standard analysis, and every one is reviewed with you by a CureSeek scientist and clinician. Our navigation services keep that expertise available throughout your care.
Integrates with all prior genomic testing and focuses on actionable genetic mutations and tumor gene expression.
Using cutting-edge bioinformatic analysis and AI, the CureSeek platform identifies tumor pathways susceptible to a range of therapeutic options, including repurposed drugs, drug combinations, and novel investigational compounds. A CureSeek scientist and clinician reviews every report with you and clearly translates it into next steps.
Our most comprehensive analysis, built from raw DNA and RNA sequencing compared directly against your own normal cells.
Rather than relying on the subset of mutations another lab flagged as actionable, we examine a far more expansive panel of gene mutations and expression changes, matching what we find against the published literature to surface possibilities a limited analysis would miss. As with our other reports, a CureSeek research scientist and clinician review the results and help translate them into a concrete plan to discuss with your treating physician.
Identifies tumor-specific neoantigens directly from your tumor data to enable personalized immunotherapies.
Tumor cells accumulate mutations that help them evade the immune system, but these can be targeted. With CSVax, neoantigens are identified from your tumor data and validated in the CureSeek laboratory, then used for personalized immunotherapies like cancer vaccines and CAR-T. Tumor-specific non-mutated antigens are also targeted to maximize the chance of response.
A CureSeek clinician and scientist conduct a thorough review of your medical records and diagnostic reports, then walk you through conventional and emerging investigational options relevant to your individual tumor. Together you'll discuss each treatment pathway so you and your physician can chart the best path forward.
A dedicated team stays by your side for the decisions that come with a serious diagnosis. Your navigator connects you directly with CureSeek's clinical and research experts, tracks how you're responding to therapy, evaluates emerging treatment options, and helps you work effectively with your treating physician.
Not sure which report fits your situation? We'll help you decide.
A practical, evidence-backed roadmap designed to be useful in the real world, for patients, families, and the oncologists guiding their care.
CASE · 0042
Personalized treatment roadmap
We're not introducing a new theory of cancer care. We're taking a methodology that has worked for individual patients for decades, and making it accessible to many more.
CureSeek is grounded in 25+ years of pathway-based oncology practice, not a theoretical model. Our methodology has been refined across hundreds of advanced patient cases.
We integrate genomics, pathology, imaging, and clinical context together, because the answer rarely lives in any single dataset alone.
Every consented case strengthens the platform. Insights become more accurate over time, and the cost of arriving at them goes down.
Reports are written to be useful to both patients and oncologists, and every recommendation is reviewed by trained clinicians before delivery.
CureSeek is built by a team operating in stealth: physician-scientists, geneticists, computational biologists, AI engineers, and repeat founders who have spent their careers at the intersection of precision medicine and technology. Collectively, they bring deep clinical, research, and engineering expertise to the mission of finding the right treatment for every patient.
Harvard-trained physician-scientists with over 25 years of experience applying pathway-based precision medicine to advanced cancer patients, with prior leadership across leading academic and clinical research institutions.
Doctorate-level human geneticists with extensive biotech R&D experience, translating genomic discovery into real-world therapeutic programs.
Advanced training across top medical and research institutions, paired with director-level experience leading computational biology and cancer research initiatives.
Builders of production LLM, RAG pipeline, and AI agent systems, backed by engineering and technology leadership across enterprise platforms and multiple healthcare startups.
Serial entrepreneurs with a track record of founding and scaling patient-centered, data-driven companies in healthcare and life sciences.
Deep expertise across AI, computer vision, natural language processing, and LLM training, paired with a history of building SaaS products and mission-critical cloud systems at scale.
Have a question that isn't here? Reach out to our team and we're happy to talk through your situation.
Tell us a little about your situation. A member of our team will follow up to walk you through the process and answer any questions.
DIRECT
For urgent medical concerns, please contact your care team or call your local emergency services.